Evidence map›Paper›PMID 40981401›Full record

ArticleGenes, chromosomes & cancer2025

IGH::IL3-Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant.

Bartosz Urbański, Karolina Miarka-Walczyk, Zuzanna Urbańska, Marta Wąsikowska, Elżbieta Sałacińska-Łoś, Karolina Bukowska-Strakova, Monika Lejman, Ewelina Jaroszek, Barbara Piątosa, Wojciech Młynarski and 2 more

Abstract readCase Reports
In one paragraph

Article in Genes, chromosomes & cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bartosz UrbańskiDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.ORCID 0009-0008-5399-4703
Karolina Miarka-WalczykDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.ORCID 0000-0001-6038-8842
Zuzanna UrbańskaDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.ORCID 0000-0002-4810-6627
Marta WąsikowskaDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.
Elżbieta Sałacińska-ŁośDepartment of Pediatric Surgery and Oncology, Medical University of Lodz, Lodz, Poland.ORCID 0000-0002-3912-7143
Karolina Bukowska-StrakovaDepartment of Clinical Immunology and Transplantology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.ORCID 0000-0001-9181-439X
Monika LejmanLaboratory of Genetic Diagnostics, Medical University of Lublin, Lublin, Poland.ORCID 0000-0002-8760-0775
Ewelina JaroszekHistocompatibility Laboratory, Children's Memorial Health Institute, Warsaw, Poland.
Barbara PiątosaHistocompatibility Laboratory, Children's Memorial Health Institute, Warsaw, Poland.ORCID 0000-0001-8949-047X
Wojciech MłynarskiDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.ORCID 0000-0003-2714-5851
Agata PastorczakDepartment of Genetic Predisposition to Cancer, Medical University of Lodz, Lodz, Poland.ORCID 0000-0003-3089-6947
Szymon JanczarDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.ORCID 0000-0001-8007-6969

Funding

Agencja Badań Medycznych 2019/ABM/01/00069Agencja Badań Medycznych 2024/ABM/03/KPO/KPOD.07.07-IW.07-00156/24-00Saving Kids with Cancer Foundation 01/2024/BN/PK
6 · The paper itself

Abstract

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with the t(5;14)(q31;q32) chromosomal translocation resulting in an IGH::IL3 fusion is an exceptionally rare lymphoid malignancy presenting with hypereosinophilia. Germline PAX5 alterations, including sequence variants and deletions, are associated with a selective susceptibility to BCP-ALL and lymphomas, based on a limited number of affected families worldwide. Here, we report a 6-year-old male with BCP-ALL with the t(5;14)(q31;q32) translocation and harboring a novel constitutional PAX5 variant (NM_016734.3:c.[295dup];[=], p.[(Ile99Asnfs*3)];[(=)]). Despite the low representation of the leukemic clone in the bone marrow, the IGH::IL3 fusion was identified by both fluorescent in situ hybridization (FISH) and optical genome mapping (OGM). Although hypereosinophilia poses a risk of multiorgan damage, our patient exhibited only pneumonia and asymptomatic neuroimaging alterations in the central nervous system. The patient achieved remission by the end of induction and is currently continuing maintenance therapy. In line with existing literature, familial segregation of the PAX5 variant demonstrated high but incomplete penetrance, as two leukemia-free mutation carriers displayed only subclinical B lymphocyte maturation abnormalities without hypogammaglobulinemia. Our report underscores the diagnostic utility of OGM, which unequivocally demonstrated the characteristic translocation. Typically, BCP-ALL in affected family members exhibits secondary somatic aberrations involving the wild-type PAX5 allele, including structural variants or loss of heterozygosity (LOH) of chromosome 9p, as well as PAX5 somatic mutations. To our knowledge, this is the first human report aligning with animal models, which suggests that secondary alterations activating the JAK-STAT pathway may potentially contribute to leukemogenesis in a PAX5 mutation background.

Indexed as

EosinophiliaImmunoglobulin Heavy ChainsOncogene Proteins, FusionPAX5 Transcription FactorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaChildGerm-Line MutationHumansInterleukin-3MaleTranslocation, GeneticIL3 protein, humanImmunoglobulin Heavy ChainsInterleukin-3Oncogene Proteins, FusionPAX5 protein, humanPAX5 Transcription Factoracute lymphoblastic leukemiaeosinophiliagermline mutationJAK–STAT pathwayleukemia predispositionoptical genome mappingPAX5

Identifiers

PMID40981401
PMCPMC12452213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.